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Insulin signaling through phosphatidylinositol 3-kinase (PI 3-kinase) activates the protein kinase Akt
through phosphorylation of its threonine 308 and serine 473 residues by the PDK1 protein kinase and the
Rictor-mammalian target of rapamycin complex (mTORC2), respectively. Remarkably, we show here that
the Rictor protein is also present in cultured adipocytes in complexes containing Myo1c, a molecular
motor that promotes cortical actin remodeling. Interestingly, the Rictor-Myo1c complex is biochemically
distinct from the previously reported mTORC2 and can be immunoprecipitated independently of
mTORC2. Furthermore, while RNA interference-directed silencing of Rictor results in the expected
attenuation of Akt phosphorylation at serine 473, depletion of Myo1c is without effect. In contrast, loss of
either Rictor or Myo1c inhibits phosphorylation of the actin filament regulatory protein paxillin at
tyrosine 118. Furthermore, Myo1c-induced membrane ruffling of 3T3-L1 adipocytes is also compromised
following Rictor knockdown. Interestingly, neither the mTORC2 inhibitor rapamycin nor the PI 3-kinase
inhibitor wortmannin affects paxillin tyrosine 118 phosphorylation. Taken together, our findings suggest
that the Rictor-Myo1c complex is distinct from mTORC2 and that Myo1c, in conjunction with Rictor,
participates in cortical actin remodeling events.
The mammalian target of rapamycin (mTOR) is an atypical
serine/threonine kinase that integrates intracellular and extra-
cellular signals from numerous pathways to regulate key cel-
lular processes, including metabolism and cell growth. The
actions of mTOR are mediated through at least two distinct
mTOR complexes that mediate signaling pathways of recep-
tors such as the insulin receptor (22, 35). In one of these
complexes, mTOR acts with the regulation-associated protein
of mTOR (Raptor) to regulate cell growth through phosphor-
ylation of the eukaryotic initiation factor 4E-binding protein
and the translational signaling protein p70 S6 kinase. A second
mTOR complex was more recently found to mediate insulin
receptor signaling to serine/threonine protein kinase B (PKB)/
Akt (reviewed in reference 20). Akt activation precedes and
mediates many of the metabolic actions of insulin, and its full
activation is associated with its insulin-dependent phosphory-
lation at threonine 308 (Thr308) and serine 473 (Ser473) (re-
viewed in reference 29). Whereas the protein 3-phosphoinosi-
tide-dependent protein kinase 1 (PDK1) had been reported to
phosphorylate Akt at Thr308 in response to insulin, the protein
kinase that phosphorylates Akt at Ser473 was unknown for a
long time. Surprisingly, this protein kinase was identified as
mTOR in a complex with rapamycin-insensitive companion of
mTOR (Rictor) (11, 24). Thus, mTOR functions within inde-
pendent complexes to modulate distinct downstream targets.
The existence of two TOR complexes was first reported for
Saccharomyces cerevisiae by Loewith et al. (19). According to
them, in S. cerevisiae TOR complex 1 (TORC1) consists of
TOR1 or TOR2, KOG1, and LST8, whereas TORC2 contains
TOR2, AVO1, AVO2, AVO3, and LST8. Other laboratories
have also reported the existence of two distinct mTOR com-
plexes. In mammalian cells, mTOR complex 1 (mTORC1)
consists of mTOR, GBL (or mLST8), and Raptor and is in-
volved in the regulation of cell size (17). mTORC2, however,
consists of mTOR, GBL, SIN1, and Rictor (or mAvo3) and is
involved in the full activation of Akt (7, 11, 13, 24, 34). Inter-
estingly, Akt phosphorylates and negatively regulates the Rheb
GTPase GAP protein TSC2, causing the activation of the
mTOR-Raptor complex and modulation of its downstream
bioeffects (reviewed in references 1 and 20).
Interestingly, another function attributed to mTORC2 is the
regulation of actin organization (23), particularly under serum-
restimulated conditions (12), but the mechanisms behind this
have not been defined. Sarbassov et al. showed that both Rictor
and mTOR knockdown in HeLa cells resulted in a disrupted actin
cytoskeleton arrangement, with actin fibers present in the whole
cell and with less prominent cortical actin than that in control cells
(23). Consistently, Jacinto et al. also showed that knocking down
components of the mTORC2 in NIH 3T3 cells prevented actin
polymerization and cell spreading, particularly in serum-restimu-
lated cells (12). In this study, we report results that provide a
novel connection between the functions of a component of the
mTORC2 and regulation of the actin cytoskeleton. We report
here that Rictor coimmunoprecipitates with the actin-based mo-
lecular motor myosin 1c (Myo1c) in 3T3-L1 adipocytes. Remark-
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ably, our studies suggest that the Rictor-Myo1c complex is bio-
chemically and functionally distinct from the Rictor-mTOR
complex. Furthermore, we report here that the Rictor-Myo1c
complex participates in dynamic cortical actin events in cultured
adipocytes.
MATERIALS AND METHODS
Materials and chemicals. Mouse anti-Myc (clone 9E10) monoclonal antibody
was purchased from Neomarkers Inc. Rabbit anti-Rictor polyclonal antibody
(BL2181) and rabbit anti-Raptor polyclonal antibody (BL888) were purchased
from Bethyl Laboratories. Rhodamine-phalloidin was purchased from Molecular
Probes. Unless otherwise mentioned, all other antibodies were purchased from
Cell Signaling Technologies. Latrunculin B was purchased from BioMol. Wort-
mannin was purchased from Sigma-Aldrich. Rapamycin was purchased from
Calbiochem.
DNA constructs. The construction of 3HA-Myo1c (IQ domain plus tail
domain) has been described previously (3). The myc-Rictor construct (Add-
gene plasmid 11367) was obtained from Addgene and has been described
previously (23). The 3HA-Myo1c(full) (motor domain plus IQ domain plus
tail domain), 3HA-Myo1c(motorIQ) (motor domain plus IQ domain),
and 3HA-Myo1c(tail) (tail domain) plasmids were constructed by subclon-
ing a Myo1c coding sequence encompassing residues 1 to 1028 (full), 1 to 759
(motorIQ), or 760 to 1028 (tail), amplified by PCR, into the HindIII and
BamHI restriction sites of pCMV5-triple HA (30) in frame with three N-
terminal hemagglutinin (HA) sequences. The green fluorescent protein
(GFP)-Myo1c plasmid was constructed by subcloning a full-length Myo1c
coding sequence into the HindIII and BamHI restriction sites of pEGFP-C1
plasmid (Clontech). The constructs were sequenced, and expression was
verified in HEK 293T cells prior to experiments.
Cell culture, cell treatments, and transfection of 3T3-L1 adipocytes and HEK
293T cells. 3T3-L1 murine fibroblasts were cultured and differentiated as de-
scribed previously (8). Differentiated 3T3-L1 adipocytes were transfected on day
4 postdifferentiation by electroporation with small interfering RNAs (siRNAs) as
described previously (15). For adipocyte treatments, cells were serum starved for
3 h in Dulbecco modified Eagle medium (DMEM) plus 1% penicillin-strepto-
mycin and then treated with the reagents described in the figure legends. For
latrunculin B treatment, 3T3-L1 adipocytes were incubated without (dimethyl
sulfoxide [DMSO]) or with 2 M latrunculin B (in DMSO) in DMEM supple-
mented with 10% fetal bovine serum (Gibco) plus 1% penicillin-streptomycin
(Gibco) for 3 h before coimmunoprecipitation (IP) experiments. HEK 293T cells
were cultured in DMEM supplemented with 10% fetal bovine serum (Gibco)
plus 1% penicillin-streptomycin (Gibco). For HEK 293T transfections, 3  106
cells per 150-mm plate were plated the day before transfection. The following
day, the 293T cells were transfected with 10 g of myc-Rictor and 10 g of either
3HA-Myo1c(full), 3HA-Myo1c(motorIQ), 3HA-Myo1c(IQtail), or
3HA-Myo1c(tail) construct DNA, using Lipofectamine 2000 (Invitrogen). At
6 h posttransfection, the medium was changed, and at 48 h posttransfection, IP
and immunoblot assays were performed.
siRNA oligonucleotides. siRNA duplexes were synthesized and purified by
Dharmacon Research, Inc. (Lafayette, CO). The following siRNA oligonucleo-
tides were used in this study: Myo1c siRNA, 5-GATCATCTGTGACCTGGT
ATT-3; Rictor siRNA, 5-GCGAGCTGATGTAGAATTGTT-3; and scram-
bled siRNA, 5-CAGTCGCGTTTGCGACTGG-3.
MEF IP assays. Rictor wild-type (WT) and knockout mouse embryonic fibro-
blasts (MEFs) were scraped into lysis buffer (20 mM Tris base, pH 7.9, 20 mM
NaCl, 1 mM EDTA, 5 mM EGTA, 20 mM beta-glycerophosphate, 1 mM di-
thiothreitol, 1 mM phenylmethylsulfonyl fluoride, 25 nM calyculin A, 1 tablet/50
ml protease inhibitor [Roche Molecular Biochemicals]) containing 0.25% 3-[(3-
cholamidopropyl)-dimethylammonio]-1-propanesulfonate (CHAPS). Lysates
were centrifuged at 13,500 rpm for 10 min. Aliquots of the supernatants con-
taining equal amounts of protein, as measured by Bradford assay (Bio-Rad),
were added to 15 l of settled protein A DynaBeads (Invitrogen) preincubated
with normal rabbit immunoglobulin G (IgG) or Rictor polyclonal antibody and
incubated at 4°C for 2 h. The Rictor antibody was raised against a prokaryotic
recombinant glutathione S-transferase (GST)–Rictor (1507-1708) polypeptide
and affinity purified by binding to a biotinylated Rictor (1507-1708) polypeptide
expressed in the pinpoint vector. Beads were washed three times with 1 ml of
lysis buffer, twice with 1 ml of lysis buffer containing 0.5 M NaCl, and again with
1 ml of lysis buffer. The beads with adsorbed proteins were added to lysis buffer
and 1 sodium dodecyl sulfate (SDS) sample buffer and heated at 95°C for 10
min. Samples were separated by SDS-polyacrylamide gel electrophoresis (SDS-
PAGE). The gel was silver stained, and bands were excised and submitted for
tryptic digestion and mass spectrum analysis.
3T3-L1 adipocyte and 293T IP assays. 3T3-L1 murine fibroblasts were grown
to confluence in 150-mm dishes and differentiated as described previously (8).
On day 7 postdifferentiation, the adipocytes were serum starved for 3 h in
DMEM plus 1% penicillin-streptomycin and either left serum starved or
stimulated with 100 nM insulin for 15 min. HEK 293T fibroblasts were also
grown and transfected in 150-mm dishes. Following treatments or transfec-
tions, cells were rinsed twice with cold phosphate-buffered saline (PBS) and
lysed in 1 ml of ice-cold S-50 lysis buffer (50 mM HEPES [pH 7.4], 5 mM
sodium pyrophosphate, 5 mM -glycerophosphate, 10 mM sodium fluoride, 2
mM EDTA, 2 mM sodium orthovanadate [Na3VO4], 1 mM phenylmethylsul-
fonyl fluoride, 10 g/ml aprotinin, 10 g/ml leupeptin) containing either 0.3%
CHAPS or 1% Triton X-100. Lysates were centrifuged at 13,000 rpm for 10
min. Total protein concentration was measured by Bradford assay (Bio-Rad).
Ten micrograms of each indicated antibody or control IgG was added to 2 mg
of total protein and incubated overnight at 4°C, followed by incubation with
swelled protein A- or protein G-Sepharose beads (Sigma) for 2 h at 4°C. The
beads with captured proteins were washed four times with lysis buffer before
being boiled for 5 min in Laemmli buffer. Samples were resolved by SDS-
PAGE and proteins transferred to polyvinylidene fluoride membranes for
immunoblotting.
Immunoblot assays. For immunoblots, cells were lysed with the indicated
detergent, and total protein concentration was measured as described previously
(14). Unless otherwise stated, 50 g of total protein was resolved by SDS-PAGE.
Proteins were transferred to polyvinylidene fluoride membranes, and membranes
were probed with specific monoclonal or polyclonal antibodies overnight at 4°C.
Bound primary antibody was visualized using horseradish peroxidase-conjugated
secondary antibody (Vector Laboratories) and enhanced chemiluminescence
reagents (Pierce).
Live-cell imaging and fixed-cell rhodamine-phalloidin staining. For live-cell
imaging experiments, day 4 3T3-L1 adipocytes were cotransfected with 50 g
plasmid DNA and 10 nM siRNA, as described previously (15), and seeded into
35-mm-diameter plastic tissue culture dishes with glass coverslip bottoms (Mat-
Tek) for live-cell imaging, six-well culture plates for fixed-cell assay, and 100-mm
culture plates for immunoblot analysis. At 72 h posttransfection, the adipocytes
were serum starved for 5 h. For live-cell imaging, adipocytes were washed three
times and incubated in Krebs-Ringer-HEPES buffer containing 0.5% bovine
serum albumin and 1 mM sodium pyruvate (KBP buffer). Images of fluorescently
labeled live adipocytes were obtained using a Yokogawa spinning-disk confocal
scan head (model CSU10; Solamere Technology Group, Salt Lake City, UT)
illuminated with an argon-ion laser (Reliant 150 M; Laser Physics, West Jordan,
UT) set at 488 nm. Images of live cells were collected at a frequency of 1 image
every 5 seconds for 10 min, with an exposure time of 100 ms. Metamorph Image
acquisition and analysis software (Universal Imaging) was used to control the
hardware, acquire data, and process final images. For fixed-cell analysis of mem-
brane ruffles, 3T3-L1 adipocytes were washed three times with PBS and fixed in
4% paraformaldehyde in PBS for 20 min at room temperature. Cells were then
permeabilized with PBS containing 0.1% Triton X-100 for 20 min and stained
with rhodamine-phalloidin (Invitrogen) for 30 min. Samples were viewed by
fluorescence microscopy using a Zeiss Axiophot2 fluorescence microscope
(Zeiss, New York, NY) and Axiovision software.
Cell quantification. Following rhodamine-phalloidin staining of adipocytes,
slides were analyzed using a Zeiss Axiophot fluorescence microscope. Adipo-
cytes were identified by the presence of lipid droplets. Fluorescein isothiocya-
nate-positive (positive for GFP empty vector [control] or GFP-Myo1c) 3T3-L1
adipocytes were evaluated for the presence of membrane ruffles. For determi-
nation of the percentage of cells showing membrane ruffles, adipocytes that were
positive for GFP-Myo1c and displayed dense actin staining at the cell periphery
were scored as positive for membrane ruffles. This number was divided by the
total number of GFP-Myo1c-positive cells analyzed. Results were reported as
percentages of cells showing membrane ruffles. For membrane ruffle size anal-
ysis, the ruffle size per cell size on GFP-Myo1c-positive adipocytes from both
scrambled siRNA- and Rictor siRNA-transfected cells was measured using
Axiovision software and normalized to GFP intensity for each cell analyzed. At
least 60 cells were analyzed for each experiment, and data shown are the aver-
ages for three independent experiments. All results are given as means  stan-
dard errors, unless stated otherwise.
Statistical analysis. Statistical differences were determined by analysis of vari-
ance. P values of 0.05 were considered significant.
4216 HAGAN ET AL. MOL. CELL. BIOL.
 at UNIV O
F M
ASS M
ED SCH on Novem
ber 16, 2009 
m
cb.asm
.org
D
ow
nloaded from
 
RESULTS
Myo1c is identified as a potential interacting partner with
Rictor in WT and Rictor-deficient MEFs. To better under-
stand how Rictor functions to promote full Akt activation
and cortical actin remodeling, we attempted to identify pro-
teins that coimmunoprecipitate with Rictor. In order to
assert the specificity of polypeptides in IP protocols, we took
advantage of Rictor-deficient MEFs derived from Rictor
knockout mice as well as MEFs from WT mice (27). Al-
though the Rictor knockout MEFs grew poorly, displaying
growth arrest after six or seven divisions, we were able to
successfully immunoprecipitate Rictor from both WT and
Rictor-deficient MEFs. In our IP experiments, the majority
of the bands recovered from the WT and Rictor-depleted
MEFs were essentially identical (Fig. 1A). However, there
were three regions on the gel where the polypeptide bands
observed for WT immunoprecipitates were missing for Rictor-
deficient MEF lysates (Fig. 1A and B [enhanced in Fig. 1B]).
Bands in these regions were excised from WT MEF lysate
lanes and analyzed by tryptic digestion and mass spectrometry.
The bands in the region near a molecular weight (MW) of
212,000 were identified to be mTOR and Rictor, thus strongly
supporting the validity of our approach. The third band, near
an MW of 116,000 (Fig. 1B), was identified as the unconven-
tional myosin Myo1c (Fig. 1C). The three bands corresponding
to mTOR, Rictor, and Myo1c that appeared in the immuno-
precipitates from WT MEFs were absent from the correspond-
ing gel segment for the IPs performed with Rictor-deficient
MEFs (Fig. 1A and B [enhanced in Fig. 1B]), suggesting that
in addition to mTOR, Rictor coimmunoprecipitates with the
unconventional myosin Myo1c.
Rictor and Myo1c coimmunoprecipitate under basal and
insulin-stimulated conditions in 3T3-L1 adipocytes. Myo1c
had previously been identified in our laboratory as an impor-
tant factor in potentiating insulin-stimulated GLUT4 translo-
cation in 3T3-L1 adipocytes (3, 4). To confirm IP between
endogenous Rictor and Myo1c in 3T3-L1 adipocytes, we per-
formed further experiments. We observed that Rictor coim-
munoprecipitated with Myo1c in 3T3-L1 adipocytes under
both basal and insulin-stimulated (100 nM) conditions (Fig.
1D). No significant changes in amounts of Myo1c that precip-
itated with Rictor occurred following insulin stimulation. Con-
sistently, by immunoprecipitating Myo1c with anti-Myo1c, we
were also able to precipitate Rictor, confirming the existence
of an endogenous Rictor-Myo1c complex in 3T3-L1 adipo-
cytes. Under lysing conditions containing 0.3% CHAPS, Rictor
but not Myo1c was also observed to coimmunoprecipitate with
mTOR, but neither Rictor nor Myo1c was observed to coim-
munoprecipitate with Raptor (Fig. 1D).
The Rictor-mTOR complex has previously been reported to
be sensitive to detergent and disrupted by 1% Triton X-100
(23). Therefore, we determined whether the Rictor-Myo1c
complex was also sensitive to detergent by immunoprecipitat-
ing Rictor or Myo1c from 3T3-L1 adipocyte lysates prepared
with 1% Triton X-100. Consistent with the previously pub-
lished results (23), mTOR did not coprecipitate with Rictor
from lysates prepared in 1% Triton X-100 (Fig. 1E). In con-
trast, the Rictor-Myo1c complex was maintained under these
conditions, and no apparent difference was observed when
cells were treated with or without insulin (Fig. 1E). Further-
more, under these lysing conditions, neither Rictor nor Myo1c
coimmunoprecipitated with mTOR or Raptor (Fig. 1E). Alto-
gether, these results confirm that there are endogenous com-
plexes containing Rictor and significant amounts of Myo1c in
3T3-L1 adipocytes under both basal and insulin-stimulated
conditions.
The Rictor-Myo1c complex, unlike the Rictor-mTOR com-
plex, is stable through chronic rapamycin treatment of cul-
tured adipocytes. The data presented in Fig. 1 suggested that
the Rictor-Myo1c complex might be biochemically distinct
from the Rictor-mTOR complex. To test this idea further,
we determined whether the Rictor-Myo1c complex was sen-
sitive to rapamycin, since prolonged rapamycin treatment of
3T3-L1 adipocytes and other cells is known to result in
physical and functional disruption of the Rictor-mTOR
complex (25). Consistent with published results, treatment
of 3T3-L1 adipocytes in cell culture medium with 100 nM
rapamycin for periods of up to 72 h significantly decreased
phosphorylation of Akt at Ser473 (Fig. 2A and B). This
correlated with a reduction in Rictor-mTOR interaction,
initially visible 48 h following rapamycin treatment (Fig. 2C
and D). These data suggest a disassembly of mTORC2,
which mediates Akt activation at Ser473. Interestingly,
protracted treatment of 3T3-L1 adipocytes with 100 nM
rapamycin did not result in a significant disruption of the
Rictor-Myo1c complex (Fig. 2C and D), suggesting that the
Rictor-Myo1c complex differs in its sensitivity to rapamycin
compared to the Rictor-mTOR complex.
The head domain of Myo1c is responsible for Myo1c’s in-
teraction with Rictor. We next sought to determine the domain
of Myo1c responsible for the interaction with Rictor. Myo1c is
a class I myosin, consisting of three major domains, namely, a
head domain, a neck domain, and a tail domain (Fig. 3A). The
head domain has conserved ATP- and actin-binding sites, and
this domain has been suggested to be important in actin poly-
merization in other class I myosins (18). The neck domain
contains three isoleucine-glutamine (IQ) binding sites that
bind calmodulin, and it has been implicated in Ca2-sensi-
tive membrane binding in hair cells (9). The Myo1c tail
domain is rich in basic amino acid residues and has been
reported to anchor the protein to inositol 1,4,5-trisphos-
phate- and phosphatidylinositol 4,5-bisphosphate-rich re-
gions of the plasma membrane (10). To determine which
domain of Myo1c is responsible for the association with
Rictor, we prepared four different triple influenza virus HA
(3HA)-tagged Myo1c constructs, namely, 3HA-Myo1c
(motorIQtail) (full length), 3HA-Myo1c(motorIQ),
3HA-Myo1c(IQtail), and 3HA-Myo1c(tail) (Fig. 3A).
Each construct was cotransfected with a myc-Rictor (full-
length) construct into HEK 293T cells, and IP studies were
performed by immunoprecipitating myc-Rictor and immuno-
blotting for HA. In these IP studies, we observed that only the
full-length [3HA-Myo1c(motorIQtail)] and 3HA-
Myo1c(motorIQ) Myo1c constructs coimmunoprecipitated
with myc-Rictor, suggesting that Rictor’s association with
Myo1c occurred through its motor domain (Fig. 3B). Further-
more, DMSO treatment alone of 3T3-L1 adipocytes had no
effect on cortical actin (Fig. 3C, top panels), but latrunculin B
treatment of 3T3-L1 adipocytes disrupted the integrity of cor-
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FIG. 1. Rictor coimmunoprecipitates with the unconventional myosin Myo1c. (A) Identification of Myo1c as an immunoprecipitating partner
of Rictor. Lysates from WT and Rictor-deficient MEFs (from Rictor knockout mice) were subjected to control rabbit IgG or Rictor polyclonal
antibody IP. After electrophoresis of samples in SDS-polyacrylamide gels, the gels were silver stained. The bands in the regions shown with solid
triangles were excised and identified by mass spectrometry analysis. The proteins that immunoprecipitated with Rictor from WT MEFs but were
absent in samples treated with control rabbit IgG and in samples derived from Rictor knockout MEFs were analyzed further. As shown in the top
panel, the upper two bands were mTOR (above MW of 212,000) and Rictor (below MW of 212,000). MWs in figures are thousands. (B) The boxed
region of the gel in panel A was enhanced for better visualization of a band in the region around an MW of 116,000. This band was identified as
Myo1c. (C) Quantification of results. Whereas five Myo1c peptides were found following IP of Rictor from WT MEFs, no Myo1c peptides were
found following IP of Rictor from Rictor-deficient MEFs. Other proteins were identified, and the numbers of peptides found following Rictor IP
from WT and Rictor knockout (KO) MEFs are shown. (D) IP between endogenous Myo1c and Rictor in 3T3-L1 adipocytes subjected to 0.3%
CHAPS lysis conditions. Differentiated 3T3-L1 adipocytes were serum starved or stimulated with 100 nM insulin for 15 min and then lysed with
0.3% CHAPS lysis buffer. IP studies were then performed using the 0.3% CHAPS 3T3-L1 adipocyte lysates and antibodies to mTOR, Rictor,
Myo1c, and nonimmune rabbit IgG (pull down). Membranes were then blotted for mTOR, Rictor, Myo1c, and Raptor. (E) IP of endogenous
Myo1c and Rictor in 3T3-L1 adipocytes under 1% Triton X-100 lysis conditions. Differentiated 3T3-L1 adipocytes were serum starved or
stimulated with 100 nM insulin for 15 min and then lysed with 1% Triton X-100 lysis buffer. IP studies were then performed using the 1% Triton
X-100 3T3-L1 adipocyte lysates and antibodies to mTOR, Rictor, Myo1c, and nonimmune rabbit IgG (pull down). Membranes were then blotted
for mTOR, Rictor, Myo1c, and Raptor. The results shown are representative of three independent experiments. In all 3T3-L1 adipocyte IP
experiments 50 g of total protein was used for lysate blots and 2 mg of total protein was used for IP experiments. , basal conditions; , 100
nM insulin stimulation.
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tical actin (Fig. 3C, bottom panels). However, we observed that
actin microfilament disruption had no effect on Rictor-Myo1c
IP (Fig. 3D), suggesting that the Rictor-Myo1c complex is not
mediated by intact actin filaments.
Myo1c is not required for mTORC2-dependent Akt activa-
tion in 3T3-L1 adipocytes. Since the Rictor-mTOR complex
was previously implicated in the phosphorylation of Akt at
serine 473 and since Rictor also coimmunoprecipitates with
Myo1c (Fig. 1), we tested whether Myo1c is necessary for
mTORC2-mediated Akt phosphorylation. With increasing
doses of insulin, Rictor knockdown cells showed a reduction in
the level of Akt phosphorylation at serine 473 compared to
control cells, whereas Myo1c-depleted cells did not (Fig. 4A
and B). These results suggest that Myo1c is not required for
mTORC2-dependent Akt activation.
Myo1c or Rictor depletion compromises paxillin phosphor-
ylation at tyrosine 118. Previous work has shown that Rictor
and the mTORC2 can also regulate actin organization (12, 23).
Interestingly, data from our laboratory suggest that Myo1c
overexpression in 3T3-L1 adipocytes induces insulin-indepen-
dent cortical actin remodeling (4). We therefore hypothesized
that the Rictor-Myo1c complex may function to regulate dy-
namic cortical actin events. Tyrosine phosphorylation of paxil-
lin has been associated with regulation of the dynamics of the
actin network (28), and experiments were designed to test the
effect of Rictor or Myo1c silencing on paxillin phosphorylation
at tyrosine 118. We observed a considerable reduction in
paxillin phosphorylation at tyrosine 118 following either Rictor
or Myo1c depletion (Fig. 5A), suggesting that both Rictor and
Myo1c are required for optimal regulation of dynamic actin
polymerization.
Paxillin phosphorylation at tyrosine 118 is not dependent on
mTOR or phosphatidylinositol 3-kinase (PI3K). Whereas ear-
lier studies with both yeast and mammalian cells suggested that
the functions of the mTORC2 complex are not compromised
by the mTOR inhibitor rapamycin (12), other results (25) (Fig.
2) imply that protracted rapamycin treatment of cells destabi-
lizes mTORC2 and compromises its ability to phosphorylate
Akt. Apart from phosphorylating Akt, the mTORC2 complex
is believed to influence actin organization, although the effect
of prolonged rapamycin treatment on actin organization has
not been studied. We observed that Akt phosphorylation at
serine 473 was less pronounced in insulin-plus-rapamycin-
treated adipocytes than in adipocytes treated with insulin
alone, indicating that the rapamycin treatment was effective, as
expected (Fig. 5B). In contrast, paxillin phosphorylation at
tyrosine 118 was unaffected by prolonged treatment of 3T3-L1
adipocytes with 100 nM rapamycin (Fig. 5B), suggesting that
mTOR activity was not necessary for paxillin phosphorylation
and actin reorganization.
Our previous work suggests that Myo1c regulates cortical
actin remodeling in a PI3K-independent manner (4), and the
results presented here (Fig. 5) are consistent with a model in
which Myo1c in complex with Rictor participates in dynamic
cortical actin polymerization. Taken together, these observa-
tions lead to the prediction that paxillin phosphorylation at
tyrosine 118 should not be affected by inhibition of the PI3K
pathway. As expected, Akt phosphorylation at serine 473 was
significantly inhibited in adipocytes treated with insulin plus
wortmannin relative to that after treatment with insulin alone
FIG. 2. Rictor-Myo1c complex is insensitive to chronic rapamycin
treatment. (A) Effect of prolonged rapamycin treatment on Akt phos-
phorylation (serine 473) in 3T3-L1 adipocytes. Differentiated 3T3-L1
adipocytes were treated with 100 nM rapamycin for 0, 1, 24, 48, or 72 h.
Adipocytes from each time point were lysed with 0.3% CHAPS lysis
buffer, and lysates were immunoblotted for Akt phosphorylation at
serine 473 as well as for total Akt. The images shown are representa-
tive blots from three independent experiments. (B) Quantitative as-
sessment of the results in panel A, based on densitometry analysis of
three independent experiments. (C) Effect of prolonged rapamycin
treatment on Rictor-mTOR and Rictor-Myo1c complex stability. IP
studies were performed by immunoprecipitating Rictor and immuno-
blotting for mTOR or Myo1c, using the 0.3% CHAPS 3T3-L1 adipo-
cyte lysates from panel A. The images shown are representative blots
from three independent experiments. (D) Quantitative assessment of
the results in panel C, based on densitometry analysis of three inde-
pendent experiments. In all 3T3-L1 adipocyte IP experiments, 50 g of
total protein was used for lysate blots and 2 mg of total protein was
used for IP experiments. R, rapamycin treatment; pAkt, phospho-Akt
(serine 473); IB, immunoblot. *, P  0.05.
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(Fig. 5C). As with rapamycin-treated cells, paxillin phosphory-
lation at tyrosine 118 was not affected by treatment of 3T3-L1
adipocytes with 100 nM wortmannin (Fig. 5C), suggesting that
paxillin phosphorylation at tyrosine 118 and dynamic cortical
actin events were regulated in a PI3K-independent manner.
These results show that neither chronic rapamycin treatment
nor wortmannin has an effect on paxillin phosphorylation at
tyrosine 118 and thus suggest that the actions of Myo1c and
Rictor on the regulation of actin dynamics are likely indepen-
dent of PI3K and mTOR.
Rictor depletion abrogates Myo1c-induced membrane ruf-
fling in 3T3-L1 adipocytes. The data presented in Fig. 1 to 5
are consistent with a model in which Myo1c and Rictor both
act in a pathway that results in cortical actin remodeling. We
previously observed that overexpression of Myo1c in 3T3-L1
adipocytes results in dramatic insulin-independent membrane
ruffling (4). To determine whether Rictor is required for
Myo1c-induced membrane ruffling, Rictor was depleted in adi-
pocytes expressing GFP-Myo1c, and these adipocytes were an-
alyzed. Immunoblot analysis revealed that Rictor levels were
significantly depleted in Rictor siRNA-transfected adipocytes
(Fig. 6A). In live-cell imaging analysis, GFP-Myo1c- and
scrambled siRNA-transfected adipocytes showed dramatic in-
sulin-independent membrane ruffling, with Myo1c concen-
trated in the regions of membrane ruffling (Fig. 6B; see Movie
S3 in the supplemental material), as we had previously ob-
served (4). Strikingly, membrane ruffling was significantly sub-
dued in GFP-Myo1c- and Rictor siRNA-transfected adipo-
cytes (Fig. 6B; see Movie S4 in the supplemental material).
Adipocytes cotransfected with GFP empty vector and scram-
bled or Rictor siRNA did not show any significant membrane
ruffling (Fig. 6B; see Movies S1 and S2 in the supplemental
material).
In order to quantitatively assess the effect of Rictor depletion
on Myo1c-induced membrane ruffling, transfected adipocytes
were serum starved prior to fixation and then permeabilized
and probed with rhodamine-phalloidin. Whereas GFP-Myo1c-
and scrambled siRNA-transfected adipocytes showed dis-
tinct and extensive membrane ruffles (Fig. 7A and B), the
incidence of membrane ruffles (shown by discontinuous corti-
cal rhodamine-phalloidin staining) in GFP-Myo1c- and Rictor
siRNA-transfected adipocytes was significantly reduced (Fig.
7A and B). Furthermore, by analyzing membrane ruffles of
both GFP-Myo1c- and scrambled siRNA-transfected and
GFP-Myo1c and Rictor siRNA-transfected adipocytes, mem-
brane ruffle size appeared to be significantly larger for GFP-
Myo1c- and scrambled siRNA-transfected adipocytes than for
GFP-Myo1c- and Rictor siRNA-transfected adipocytes (Fig.
7C). GFP empty vector-transfected adipocytes showed no sig-
nificant membrane ruffles (Fig. 7A). Together, these data sug-
FIG. 3. Rictor coimmunoprecipitates with the motor domain of Myo1c. (A) Triple-HA-tagged Myo1c constructs are shown. In addition to the
full-length Myo1c(motorIQtail) construct, Myo1c(motorIQ), Myo1c(IQtail), and Myo1c(tail) constructs were prepared for cotransfection
and IP experiments with a myc-tagged Rictor construct. (B) IP studies of myc-Rictor and 3HA-Myo1c constructs. HEK 293T cells were
cotransfected with myc-Rictor and either 3HA-Myo1c(full), 3HA-Myo1c(motorIQ), 3HA-Myo1c(IQtail), or 3HA-Myo1c (tail). At 48 h
posttransfection, cells were lysed with 1% Triton X-100 lysis buffer. Lysates were immunoprecipitated with the myc tag and immunoblotted for the
HA or myc tag. Nonimmune rabbit IgG was used as a control for IP. The image shown is a representative blot from three independent experiments.
(C) Assessment of latrunculin B effect on cortical actin integrity. 3T3-L1 adipocytes were incubated with or without 2 M latrunculin B. At 3 h
postincubation, cells were fixed with 4% paraformaldehyde, permeabilized with 0.1% Triton X-100, and stained with rhodamine-phalloidin for
cortical actin analysis. The images shown are representative frames of cells for each condition. Bars, 10 m. (D) IP studies of endogenous Rictor
and Myo1c following latrunculin B treatment. 3T3-L1 adipocytes were incubated without () or with () 2 M latrunculin B. At 3 h
postincubation, cells were lysed with 0.1% Triton X-100 lysis buffer. Lysates were immunoprecipitated with Rictor and immunoblotted for Myo1c.
Nonimmune rabbit IgG was used as a control for IP. The images shown are representative blots from three independent experiments. MWs in the
figure are thousands.
FIG. 4. Rictor depletion but not Myo1c depletion results in de-
creased Akt (serine 473) phosphorylation. (A) siRNA-mediated Rictor
and Myo1c silencing. Differentiated 3T3-L1 adipocytes were trans-
fected with either scrambled siRNAs (S), siRNAs to Rictor (R), or
siRNAs to Myo1c (M). At 72 h posttransfection, the adipocytes were
serum starved for 3 h and then left serum starved (0.0 nM insulin) or
stimulated with 0.1 nM, 1 nM, 10 nM, or 100 nM insulin for 15 min.
Lysates from each condition were analyzed by immunoblotting to
determine the levels of Rictor depletion, Myo1c depletion, Akt phos-
phorylation (serine 473), and total Akt. The images shown are repre-
sentative immunoblots from three independent experiments.
(B) Quantitative assessment of the results in panel A, based on den-
sitometry analysis of three independent experiments. Significance lev-
els for comparison of Myo1c siRNA-transfected cells to Rictor siRNA-
transfected cells are as follows: *, P  0.05; **, P  0.01. Significance
levels for comparison of scrambled siRNA-transfected cells to Rictor
siRNA-transfected cells are as follows: #, P  0.05; ##, P  0.01.
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gest that Rictor is required for Myo1c-induced, insulin-inde-
pendent membrane ruffling in 3T3-L1 adipocytes.
DISCUSSION
The key novel finding reported here is the unexpected IP of
the unconventional myosin Myo1c with Rictor, a previously
identified protein in the mTORC2 that regulates Akt activa-
tion (Fig. 1 to 3). Remarkably, the data presented indicate that
there are at least two biochemically and functionally distinct
Rictor complexes in 3T3-L1 adipocytes, namely, the Rictor-
mTOR complex (mTORC2) and the Rictor-Myo1c complex
(Fig. 8). The Rictor-mTOR complex is sensitive to Triton
X-100 and long-term treatment of cells with rapamycin,
whereas the Rictor-Myo1c complex is not (Fig. 2). Function-
ally, the Rictor-mTOR complex regulates Akt phosphorylation
at Ser473 (Fig. 4), while the Rictor-Myo1c complex seems to
participate in cortical actin remodeling and membrane ruffling
(Fig. 6 and 7).
In a previous study designed to understand the role of
Myo1c in GLUT4 trafficking and membrane dynamics, we
observed that Myo1c overexpression induced dramatic cor-
tical actin remodeling (membrane ruffling) in 3T3-L1 adi-
pocytes, in a serum- and insulin-independent manner (4).
This observation suggested that Myo1c might mediate the
effect of insulin on membrane ruffling in 3T3-L1 adipocytes,
which is supported by our observation that Myo1c depletion
in 3T3-L1 adipocytes does indeed attenuate insulin-induced
membrane ruffling (data not shown). Interestingly, expres-
sion of Myo1c in cultured adipocytes induces membrane
ruffling even in the presence of wortmannin, suggesting that
Myo1c may function downstream or independent of PI3K in
activating membrane ruffling. Our studies here suggest that
formation and maintenance of the Rictor-Myo1c complex
are not dependent on insulin, rapamycin, or wortmannin
(Fig. 1, 2, and 4). Therefore, to determine the functional
relevance of Rictor’s association with Myo1c, we performed
experiments that focused on Myo1c-induced, not insulin-,
FIG. 5. Rictor and Myo1c both regulate paxillin phosphorylation at tyrosine 118, in an mTOR- and PI3K-independent manner. (A) Rictor and
Myo1c silencing compromises paxillin phosphorylation at tyrosine 118 (Y118). Differentiated 3T3-L1 adipocytes were transfected with either
scrambled siRNAs, siRNAs to Rictor, or siRNAs to Myo1c. At 72 h posttransfection, the adipocytes were lysed in 1% SDS buffer and immunoblots
were performed to assess Rictor, Myo1c, phospho-paxillin (Y118), and total paxillin levels. The images shown are representative blots from three
independent experiments. (B) Effect of prolonged rapamycin treatment on phospho-paxillin level. Differentiated 3T3-L1 adipocytes were either
left unstimulated and untreated (/), left unstimulated but treated with 100 nM rapamycin for 72 h (/), stimulated with 100 nM insulin for
15 min but left untreated (/), or stimulated with 100 nM insulin for 15 min and treated with 100 nM rapamycin for 72 h (/). In all cases
where it was present, insulin was added for the final 15 min of the experiment. Following stimulation and treatment, the adipocytes were lysed in
1% SDS and immunoblots were performed to assess phospho-paxillin (Y118), total paxillin, phospho-Akt (S473), and total Akt levels. The images
shown are representative blots from three independent experiments. (C) Effect of wortmannin treatment on phospho-paxillin level. Differentiated
3T3-L1 adipocytes were either left unstimulated and untreated (/), treated with 100 nM wortmannin for 30 min but left unstimulated (/),
left untreated but stimulated with 100 nM insulin for 15 min (/), or treated with 100 nM wortmannin for 30 min and stimulated with 100 nM
insulin for 15 min (/). Following treatment and stimulation, the adipocytes were lysed and immunoblots were performed to assess phospho-
paxillin (Y118), total paxillin, phospho-Akt (S473), and total Akt levels. The images shown are representative blots from three independent
experiments. Ins, 100 nM insulin; Rap, 100 nM rapamycin; Wort, 100 nM wortmannin.
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rapamycin-, or wortmannin-dependent, membrane ruffling.
By using insulin-independent, Myo1c-induced membrane
ruffling as the readout for a specific Myo1c-dependent
event, we could test whether or not Rictor participated in
this event. Furthermore, our previous results (Fig. 1 to 5)
suggested that the Rictor-mTOR complex is independent of
the Rictor-Myo1c complex, and thus we eliminated possible
contributions of the Rictor-mTOR complex (whose activity
is dependent on serum and insulin) and observed the role of
Rictor directly on Myo1c function. The data presented in
Fig. 6 and 7 clearly show that Rictor is required for Myo1c-
mediated membrane ruffling. Taken together, our results
suggest that Myo1c overexpression induces insulin-indepen-
dent cortical actin remodeling and that Rictor depletion
attenuates this Myo1c-induced event.
Tyrosine 118 phosphorylation of the scaffolding protein
paxillin is thought to be an important regulator of cytoskel-
eton-dependent changes in a cell (reviewed in reference 28).
Insulin is known to induce dramatic 3T3-L1 adipocyte mem-
brane ruffling (reviewed in reference 16), but we found that
insulin stimulation does not result in a significant increase in
the phosphorylation state of paxillin at tyrosine 118 (Fig. 5).
This observation suggests that insulin-induced membrane
ruffling in 3T3-L1 adipocytes has no effect on the phosphor-
ylation state of paxillin at tyrosine 118, consistent with pre-
vious findings (31). However, we observed that Rictor or
Myo1c depletion resulted in a significant reduction in
paxillin phosphorylation at tyrosine 118 (Fig. 5). These data
indicate that the effects of insulin versus the effects of ex-
pression of Myo1c are mediated, at least in part, by inde-
pendent mechanisms leading to the induction of membrane
ruffling in 3T3-L1 adipocytes. Whereas our result is novel, it
is consistent with previously published work from our lab
(21) and others (31) suggesting that there may be mecha-
nisms that regulate actin dynamics in adipocytes that are
distinct from the insulin-dependent pathways. Furthermore,
the idea that the Rictor-Myo1c complex participates in cor-
tical actin remodeling events that are distinct from the
events regulated by insulin is supported by our observation
that neither PI3K inhibition by wortmannin nor mTOR in-
hibition by rapamycin affects paxillin phosphorylation at
tyrosine 118 in 3T3-L1 adipocytes (Fig. 5). Further work is
required to uncover the underlying mechanisms that regu-
late actin dynamics in response to insulin and Myo1c.
FIG. 6. Rictor depletion attenuates Myo1c-induced, insulin-independent membrane ruffling in 3T3-L1 adipocytes. (A) Rictor knockdown in
3T3-L1 adipocytes cotransfected with GFP-Myo1c and scrambled siRNA or Rictor siRNA. Differentiated 3T3-L1 adipocytes were cotransfected
with GFP empty vector (GFP-E/V) or GFP-Myo1c and scrambled siRNA or Rictor siRNA. At 72 h posttransfection, a subset of these cells were
lysed in 1% SDS and immunoblots were performed to assess Rictor and Akt (loading control) levels. (B) Rictor depletion abrogates Myo1c-
induced, insulin-independent membrane ruffling in 3T3-L1 adipocytes (live-cell analysis). Differentiated 3T3-L1 adipocytes were cotransfected with
GFP empty vector or GFP-Myo1c and scrambled siRNA or Rictor siRNA. At 72 h posttransfection, a subset of these cells were serum starved for
5 h and then incubated in Krebs-Ringer-HEPES buffer containing 0.5% bovine serum albumin and 1 mM sodium pyruvate. Membrane ruffling was
observed by live monitoring of the cells for 10 min, with imaging done at 5-s intervals. The images shown are bright-field images and images at
three time frames, each 5 min apart, for a representative GFP empty vector- and scrambled siRNA-transfected adipocyte, a GFP-Myo1c- and
scrambled siRNA-transfected adipocyte, a GFP empty vector- and Rictor siRNA-transfected adipocyte, and a GFP-Myo1c- and Rictor siRNA-
transfected adipocyte. Scr, scrambled siRNA; Ric, Rictor siRNA. Bars, 10 m.
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The participation of class I myosins in actin dynamics has
been reported for yeast class I myosins, such as Myo3p and
Myo5p, which are activated through a phosphorylation event at
a serine residue in the head domain by members of the Ste20p
family (32, 33). Even though there is no direct evidence of this
regulation for mammalian myosin I orthologs, it is possible
that mammalian class I myosins could be regulated by factors
that interact with their head domains. Our finding that the
FIG. 7. Rictor depletion abrogates Myo1c-induced, insulin-independent membrane ruffling in 3T3-L1 adipocytes (fixed-cell analysis). (A) Differen-
tiated 3T3-L1 adipocytes were cotransfected with GFP empty vector or GFP-Myo1c and scrambled siRNA or Rictor siRNA and then seeded on glass
coverslips. At 72 h posttransfection, these cells were serum starved for 5 h, fixed with 4% paraformaldehyde, permeabilized with 0.1% Triton X-100, and
stained with rhodamine-phalloidin for membrane ruffle analysis. The images show representative adipocytes for each condition. Bars, 10m. (B) For each
condition, the percentage of ruffled cells was determined by scoring the number of GFP-Myo1c-positive cells that had membrane ruffles against the total
number of cells counted. At least 60 cells were evaluated in each experiment. The averaged data from three independent experiments are shown, with
standard deviations. **, P 0.01. (C) Effect of Rictor knockdown on Myo1c-induced, insulin-independent membrane ruffle size. 3T3-L1 adipocytes were
transfected and prepared as described above. For each condition, membrane ruffle size was determined by measuring the size of discernible membrane
ruffles for GFP-Myo1c-positive cells under each condition and dividing it by the total size of the cell, as determined using Axiovision software. For each
cell evaluated, the GFP intensity was determined and the average ruffle size/total cell size ratio from each condition was normalized to the average GFP
intensity of all evaluated cells under each condition. At least 60 cells were assessed in each experiment. The box-and-whisker plots show (from the top
down) maximum, third quartile, median, first quartile, and minimum values. **, P  0.01.
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Myo1c head domain is important for Myo1c association with
Rictor supports such a hypothesis, but further work is required
to test this.
Finally, a potential mechanism by which Rictor may regulate
cortical actin remodeling is through activation of small GTPase
activity. AVO3, the budding yeast ortholog of Rictor, is re-
ported to contain a RasGEFN domain that exists N-terminal
to the catalytic GDP/GTP exchange domain in some guanine
nucleotide exchange factors for Ras-like small GTPases (6).
This raises the possibility that Rictor may activate GTPase
signaling (19). Rho family GTPases play an important role in
the regulation of cortical actin dynamic events in numerous cell
types (2), including adipocytes (16), and in NIH 3T3 cells
mTORC2 has been shown to regulate actin organization
through Rho family GTPases (12). It is thus conceivable that
Myo1c in complex with Rictor could be part of a machinery
that also leads to the activation of Rho family GTPases in
3T3-L1 adipocytes. Future work will be needed to test these
FIG. 8. Working model suggesting that Rictor may function in two
pathways. Our data suggest that Myo1c and Rictor form a complex in
3T3-L1 adipocytes that is biochemically and functionally distinct from
the Rictor-mTOR complex. While the Rictor-mTOR complex (I) that
phosphorylates and activates Akt is rapamycin sensitive, our data sug-
gest that the Rictor-Myo1c complex (II) acts in an insulin-, rapamycin-,
and wortmannin-insensitive manner to participate in dynamic cortical
actin events.
FIG. 7—Continued.
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hypotheses and to determine the mechanism through which
Rictor-Myo1c participates in cortical actin dynamics.
ACKNOWLEDGMENTS
We thank Paul Furcinitti for assistance with live-cell imaging exper-
iments and Vishwajeet Puri for useful suggestions. Part of this work
was performed using resources of the University of Massachusetts
Medical School Digital Imaging Core Facility.
This work was supported by National Institutes of Health grant
DK17776 to J.A. and grants DK063023 and DK30898 to M.P.C.
REFERENCES
1. Avruch, J., K. Hara, Y. Lin, M. Liu, X. Long, S. Ortiz-Vega, and K.
Yonezawa. 2006. Insulin and amino-acid regulation of mTOR signaling and
kinase activity through the Rheb GTPase. Oncogene 25:6361–6372.
2. Bar-Sagi, D., and A. Hall. 2000. Ras and Rho GTPases: a family reunion.
Cell 103:227–238.
3. Bose, A., A. Guilherme, S. I. Robida, S. M. C. Nicoloro, Q. L. Zhou, Z. Y.
Jiang, D. P. Pomerleau, and M. P. Czech. 2002. Glucose transporter recy-
cling in response to insulin is facilitated by myosin Myo1c. Nature 420:821–
824.
4. Bose, A., S. Robida, P. S. Furcinitti, A. Chawla, K. Fogarty, S. Corvera, and
M. P. Czech. 2004. Unconventional myosin Myo1c promotes membrane
fusion in a regulated exocytic pathway. Mol. Cell. Biol. 24:5447–5458.
5. Reference deleted.
6. De Virgilio, C., and R. Loewith. 2006. Cell growth control: little eukaryotes
make big contributions. Oncogene 25:6392–6415.
7. Frias, M., C. Thoreen, J. Jaffe, W. Schroder, T. Sculley, S. Carr, and D.
Sabatini. 2006. mSin1 is necessary for Akt/PKB phosphorylation, and its
isoforms define three distinct mTORC2s. Curr. Biol. 16:1865–1870.
8. Harrison, S. A., J. M. Buxton, B. M. Clancy, and M. P. Czech. 1990. Insulin
regulation of hexose transport in mouse 3T3-L1 cells expressing the human
HepG2 glucose transporter. J. Biol. Chem. 265:20106–20116.
9. Hirono, M., C. S. Denis, G. P. Richardson, and P. G. Gillespie. 2004. Hair
cells require phosphatidylinositol 4,5-bisphosphate for mechanical transduc-
tion and adaptation. Neuron 44:309–320.
10. Hokanson, D. E., and E. M. Ostap. 2006. Myo1c binds tightly and specifically
to phosphatidylinositol 4,5-bisphosphate and inositol 1,4,5-trisphosphate.
Proc. Natl. Acad. Sci. USA 103:3118–3123.
11. Hresko, R. C., and M. Mueckler. 2005. mTOR. RICTOR is the Ser473
kinase for Akt/protein kinase B in 3T3-L1 adipocytes. J. Biol. Chem. 280:
40406–40416.
12. Jacinto, E., R. Loewith, A. Schmidt, S. Lin, M. A. Ruegg, A. Hall, and M. N.
Hall. 2004. Mammalian TOR complex 2 controls the actin cytoskeleton and
is rapamycin insensitive. Nat. Cell Biol. 11:1122–1128.
13. Jacinto, E., V. Facchinetti, D. Liu, N. Soto, S. Wei, S. Y. Jung, Q. Huang, J.
Qin, and B. Su. 2006. SIN1/MIP1 maintains Rictor-mTOR complex integrity
and regulates Akt phosphorylation and substrate specificity. Cell 127:125–
137.
14. Jiang, Z. Y., A. Chawla, A. Bose, M. Way, and M. P. Czech. 2002. A phos-
phatidylinositol 3-kinase-independent insulin signaling pathway to N-WASP/
Arp2/3/F-actin required for GLUT4 glucose transporter recycling. J. Biol.
Chem. 277:509–515.
15. Jiang, Z. Y., Q. L. Zhou, K. A. Coleman, M. Chouinard, Q. Boese, and M. P.
Czech. 2003. Insulin signaling through Akt/protein kinase B analyzed by
small interfering RNA-mediated gene silencing. Proc. Natl. Acad. Sci. USA
100:7569–7574.
16. Kanzaki, M. 2006. Insulin receptor signals regulating GLUT4 translocation
and actin dynamics. Endocr. J. 53:267–293.
17. Kim, D. H., D. D. Sarbassov, S. M. Ali, J. E. King, R. R. Latek, H. Erdjument-
Bromage, P. Tempst, and D. M. Sabatini. 2002. mTOR interacts with raptor to
form a nutrient-sensitive complex that signals to the cell growth machinery. Cell
110:163–175.
18. Lechler, T., A. Shevchenko, and R. Li. 2000. Direct involvement of yeast type
I myosins in Cdc42-dependent actin polymerization. J. Cell Biol. 148:363–
373.
19. Loewith, R., E. Jacinto, S. Wullschleger, A. Lorberg, J. L. Crespo, D. Bonenfant,
W. Oppliger, P. Jenoe, and M. N. Hall. 2002. Two TOR complexes, only one of
which is rapamycin sensitive, have distinct roles in cell growth control. Mol. Cell
10:457–468.
20. Martin, D. E., and M. N. Hall. 2005. The expanding TOR signaling network.
Curr. Opin. Cell Biol. 17:158–166.
21. Park, J. G., A. Bose, J. Leszyk, and M. P. Czech. 2001. PYK2 as a mediator
of endothelin-1/Galpha 11 signaling to GLUT4 glucose transporters. J. Biol.
Chem. 276:47751–47754.
22. Sabatini, D. M. 2006. mTOR and cancer: insights into a complex relation-
ship. Nat. Rev. Cancer 6:729–734.
23. Sarbassov, D. D., S. M. Ali, D. H. Kim, D. A. Guertin, R. R. Latek, H.
Erdjument-Bromage, P. Tempst, and D. M. Sabatini. 2004. Rictor, a novel
binding partner of mTOR, defines a rapamycin-insensitive and raptor-inde-
pendent pathway that regulates the cytoskeleton. Curr. Biol. 14:1296–1302.
24. Sarbassov, D. D., D. A. Guertin, S. M. Ali, and D. M. Sabatini. 2005.
Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex.
Science 307:1098–1101.
25. Sarbassov, D. D., S. M. Ali, S. Sengupta, J. H. Sheen, P. P. Hsu, A. F. Bagley,
A. I. Markhard, and D. M. Sabatini. 2006. Prolonged rapamycin treatment
inhibits mTORC2 assembly and Akt/PKB. Mol. Cell 22:159–168.
26. Reference deleted.
27. Shiota, C., J. T. Woo, J. Lindner, K. D. Shelton, and M. A. Magnuson. 2006.
Multiallelic disruption of the rictor gene in mice reveals that mTOR complex
2 is essential for fetal growth and viability. Dev. Cell 11:583–589.
28. Turner, C. E. 2000. Paxillin and focal adhesion signaling. Nat. Cell Biol.
2:E231–E236.
29. Vanhaesebroeck, B., and D. R. Alessi. 2000. The PI3K-PDK1 connection:
more than just a road to PKB. Biochem. J. 346:561–576.
30. Virbasius, J. V., X. Song, D. P. Pomerleau, Y. Zhan, G. W. Zhou, and M. P.
Czech. 2001. Activation of the Akt-related cytokine-independent survival
kinase requires interaction of its phox domain with endosomal phosphati-
dylinositol 3-phosphate. Proc. Natl. Acad. Sci. USA 98:12908–12913.
31. Wang, Q., P. J. Bilan, and A. Klip. 1998. Opposite effects of insulin on focal
adhesion proteins in 3T3-L1 adipocytes and in cells overexpressing the in-
sulin receptor. Mol. Biol. Cell 9:3057–3069.
32. Wu, C., S. F. Lee, E. Furmaniak-Kazmierczak, G. P. Cote, D. Y. Thomas, and
E. Leberer. 1996. Activation of myosin-I by members of the Ste20p protein
kinase family. J. Biol. Chem. 271:31787–31790.
33. Wu, C., V. Lytvyn, D. Y. Thomas, and E. Leberer. 1997. The phosphorylation
site for Ste20p-like protein kinases is essential for the function of myosin-I in
yeast. J. Biol. Chem. 272:30623–30626.
34. Yang, Q., K. Inoki, T. Ikenoue, and K. L. Guan. 2006. Identification of Sin1
as an essential TORC2 component required for complex formation and
kinase activity. Genes Dev. 20:2820–2832.
35. Yang, Q., and K. L. Guan. 2007. Expanding mTOR signaling. Cell Res.
17:666–681.
4226 HAGAN ET AL. MOL. CELL. BIOL.
 at UNIV O
F M
ASS M
ED SCH on Novem
ber 16, 2009 
m
cb.asm
.org
D
ow
nloaded from
 
